As discussed by Petzer et al. [125], TET2 mutations are common in MDS and have been shown to impair natural killer (NK) cell function by altering methylation patterns, leading to reduced expression of cytotoxic effector molecules such as KIRs, perforin, and TNF-α. This evidence concerns the gene TET2 and myelodysplastic syndrome.